adenosine has been researched along with Hyperplasia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Han, J; Hu, L; Li, J; Shen, L; Song, B; Wang, Q; Wang, Z; Zhu, B | 1 |
| Chang, KS; Hong, YJ; Jeong, MH; Kim, HK; Kim, JH; Kim, MC; Kim, SS; Lim, HC; Lim, KS; Park, KH | 1 |
| Adriaenssens, T; Barbato, E; Bax, JJ; De Vroey, F; Di Serafino, L; Pyxaras, SA; Reiber, JHC; Toth, G; Tu, S; Ughi, GJ; Wijns, W | 1 |
| Acikel, U; Albayrak, G; Erdal, AC; Ergur, B; Kalkan, S; Karabay, O; Silistreli, E | 1 |
| Ay, D; Eris, C; Goncu, MT; Gul, NY; Sürer, S; Toktas, F; Turk, T; Vural, AH; Yalcınkaya, U; Yavuz, S | 1 |
| Arasa, J; Martos, P; Montesinos, MC; Terencio, MC; Valcuende-Cavero, F | 1 |
| Adeola, O; Chen, R; Fay, WP; Jeong, SS; Ji, Y; Strawn, TL | 1 |
| Dubey, RK; Gillespie, DG; Jackson, EK; Shue, H | 1 |
| Dumont, JE; Ledent, C; Parmentier, M; Vassart, G | 1 |
| Dao, TL | 1 |
10 other study(ies) available for adenosine and Hyperplasia
| Article | Year |
|---|---|
Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m
Topics: Adenosine; Animals; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p16; Humans; Hyperplasia; Male; Muscle, Smooth, Vascular; Panax notoginseng; Rats; Rats, Sprague-Dawley; Saponins; Signal Transduction; Tunica Intima; WT1 Proteins | 2020 |
Effects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis model.
Topics: Adenosine; Animals; Clopidogrel; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Hyperplasia; Male; Neointima; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Random Allocation; Swine; Ticagrelor; Ticlopidine; Tomography, Optical Coherence; Treatment Outcome | 2017 |
In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study.
Topics: Absorbable Implants; Adenosine; Adult; Aged; Cardiac Catheterization; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Hyperplasia; Infusions, Intravenous; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Predictive Value of Tests; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vasodilator Agents | 2018 |
Inhibitory effect of adenosine on intimal hyperplasia and proliferation of smooth muscle cells in a carotid arterial anastomosis animal model.
Topics: Adenosine; Anastomosis, Surgical; Animals; Carotid Arteries; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; Hyperplasia; Myocytes, Smooth Muscle; Neointima; Rabbits; Tunica Intima | 2015 |
Effect of the P2Y12 antagonist ticagrelor on neointimal hyperplasia in a rabbit carotid anastomosis model†.
Topics: Adenosine; Anastomosis, Surgical; Animals; Biopsy; Carotid Arteries; Carotid Stenosis; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperplasia; Immunohistochemistry; Neointima; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rabbits; Receptors, Purinergic P2Y12; Recurrence; Ticagrelor; Transforming Growth Factor beta | 2014 |
Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Administration, Topical; Animals; Anti-Inflammatory Agents; Cell Proliferation; Collagen; Cytokines; Dexamethasone; Disease Models, Animal; Epidermis; Female; Hyperplasia; Inflammation; Mice; Peroxidase; Phenethylamines; Skin Diseases; Tetradecanoylphorbol Acetate | 2014 |
Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
Topics: Adenosine; Adenosine Triphosphatases; Animals; Apyrase; Blood Platelets; Blood Vessels; Carotid Arteries; Cell Movement; Cell Proliferation; Coronary Vessels; Endothelial Cells; Endothelium, Vascular; Hemostasis; Humans; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet Aggregation; Prothrombin Time; Recombinant Proteins; Solubility; Thrombosis; Tunica Intima | 2017 |
A(2B) receptors mediate antimitogenesis in vascular smooth muscle cells.
Topics: 2-Chloroadenosine; Adenine; Adenosine; Adenosine Kinase; Adenosine-5'-(N-ethylcarboxamide); Animals; Anticoagulants; Antihypertensive Agents; Aorta, Abdominal; Becaplermin; Cell Division; Dinucleoside Phosphates; Enzyme Inhibitors; Hyperplasia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Phenethylamines; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Thymidine; Tritium; Tubercidin; Vasodilator Agents; Xanthines | 2000 |
Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism.
Topics: Adenosine; Animals; Blotting, Northern; Brain; Cattle; Cell Membrane; Cyclic AMP; Dogs; Hyperplasia; Hyperthyroidism; Kinetics; Methimazole; Mice; Mice, Transgenic; Phenethylamines; Poly A; Promoter Regions, Genetic; Receptors, Purinergic; Receptors, Thyrotropin; Reference Values; RNA; RNA, Messenger; Thyroglobulin; Thyroid Gland; Thyroxine; Triiodothyronine | 1992 |
Inhibition of tumor induction in chemical carcinogenesis in the mammary gland.
Topics: Adenofibroma; Adenosine; Animals; Carbon Isotopes; Carcinogens; Castration; Cesarean Section; DNA; Enzyme Induction; Estradiol; Estrogens; Estrus; Female; Flavins; Formates; Gonadotropins, Equine; Hydrocarbons; Hyperplasia; Hypothalamus; Lactation; Liver; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylcholanthrene; Mitosis; Ovary; Phenothiazines; Pituitary Gland; Pregnancy; Progesterone; Prolactin; RNA; Thymidine; Time Factors; Tritium | 1971 |